Related Experiment Videos

[Isoenzyme BB of creatine phosphokinase: its place in pulmonary pathology (author's transl)]

M Paris, P Leclerc, B Lebeau

    La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
    |February 18, 1980
    PubMed

    Insights

    Researchers identified creatine kinase BB isoenzyme (CK EC 2.7.3.2) in 29 of 58 lung cancer patients. This specific isoenzyme shows potential as a reliable cancer marker for the bronchopulmonary tract, with no false positives in controls.

    Area of Science:

    • Biochemistry
    • Oncology
    • Pulmonology

    Context:

    • Bronchopulmonary cancer diagnosis and monitoring remain challenging.
    • Biomarkers are crucial for early detection and effective treatment of lung cancers.
    • Creatine kinase (CK) isoenzymes are indicators of tissue damage and cellular processes.

    Purpose:

    • To investigate the presence and diagnostic potential of creatine kinase BB isoenzyme (CK EC 2.7.3.2) in patients with bronchopulmonary cancer.
    • To evaluate CK BB isoenzyme as a potential cancer marker for the lung.
    • To assess the specificity of CK BB isoenzyme detection in patient sera and pleural effusions.

    Summary:

    • Creatine kinase BB isoenzyme (CK EC 2.7.3.2) was detected in the sera or pleural effusions of 29 out of 58 patients diagnosed with bronchopulmonary cancer.
    • Lung homogenates and alveolar macrophages were found to be rich in this specific CK BB isoenzyme fraction.
    • No false positive results were observed in the sera of the control group, indicating high specificity.

    Impact:

    • This study suggests that CK BB isoenzyme may serve as a novel and specific cancer marker for the bronchopulmonary tract.
    • Further research could validate CK BB isoenzyme as a valuable tool in lung cancer diagnostics.
    • Potential for improved early detection and patient management strategies for lung cancer.

    Related Concept Videos